Clinical Trial Update: Domperidone in Treating Patients With Gastrointestinal Disorders [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating domperidone for several gastrointestinal disorders is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Esophagitis
• Gastroesophageal Reflux Disease
• Gastroparesis
• Heartburn
• Nausea and Vomiting

Drugs mentioned

• Domperidone (domperidone)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Digestive System Disorder, Dyspepsia | Phase 3 | Status: RECRUITING